NewGen is one of the select few companies authorized to import and supply through the Named Patient Program (NPP) when an unmet medical need arises.

As a registered and accredited supplier in Turkey, we work closely with health authorities to ensure access, and meet the unique needs of patients and provide affordable solutions to the healthcare system.

We focused on providing market access to specialty medicines for unmet needs mainly in orphan disease space.

Newgen Pharma works with wide range of original and generic drug manufacturers from all over the world and provides orphan drugs to the patients.

Newgen Pharma works with the experienced professionals for licencing products with its strong network spanning including private and public institutions.

Through strategic partnerships with global, regional and local pharmaceutical companies and therapeutic area-specific stakeholders, we navigate regulatory pathways, market dynamics, and access challenges to ensure medicines reach patients safely, compliantly and on time.